New Batch of Actinium-225 Available in December
A new batch of accelerator-produced actinium-225 (Ac-225) is planned to be available through the DOE Isotope Program in mid-December. This alpha-emitting radionuclide and its decay product bismuth-213 (Bi-213), from an Ac-225/Bi-213 generator, have gained considerable interest within the medical community for their radioimmunotherapy applications.
The Ac-225 (half-life of 9.92 days) is produced at the DOE Isotope Program’s high-energy accelerators at both Los Alamos and Brookhaven National Laboratories through the proton bombardment of natural thorium targets, then separated and purified at Oak Ridge National Laboratory. Please visit the product catalog to view product specifications and to request a quote.
For further inquiries about the availability of Ac-225, please contact the NIDC at email@example.com.